| Exchange: |
NGM |
| Last Open: |
0.43 |
| Day Range: |
0.42 - 0.46 |
| Last Close: |
0.43 |
| Change: |
-0.01 (N/A) |
| Volume: |
209,782 |
| Avg Vol (3m): |
239,921 |
| 52wk Range: |
0.38 - 1.85 |
| Market Cap: |
34,000,000 |
| EBITDA: |
N/A |
| Revenue: |
2,700,000 |
Address:
Helicos BioSciences Corporation
One Kendall Square
Building 700
Cambridge, MA 02139
United States
Web Site:
|
(HLCS) DIVIDEND RATINGS:
| Overall Rating: |
|
| The overall rating is a weighted average of the three other rated categories listed below. It is a general indication of the health of a dividend. Rating last changed:
Never |
|
| Dividend Yield: |
|
| This indicator measures a stock's current dividend yield, and compares it to similar stocks and historical yields. |
| Dividend History: |
|
| The rating for dividend history is determined by looking back at the frequency and amount of historical dividend payments. |
| Div. Increases: |
|
| This indicator measures a stock's history of dividend increases; consistent increases over time will produce a favorable rating.
|
|
HEADLINES FOR (HLCS):
OTHER DRUGS - GENERIC COMPANIES:
Mylan, Inc. (MYL)
Watson Pharmaceuticals Inc. (WPI)
Par Pharmaceutical Companies Inc. (PRX)
Hi Tech Pharmacal Co. Inc. (HITK)
Caraco Pharmaceutical Laboratories Ltd. (CPD)
SEE FULL LIST
|
